12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Friday's intraday session, several healthcare stocks experienced significant movements. IMAC Holdings, Virios Therapeutics, Regencell Bioscience, Ontrak, Outlook Therapeutics, and Biolase were among the gainers, with IMAC Holdings leading with a 91.5% increase. On the downside, SINTX Techs, Nkarta, Cutera, 180 Life Sciences, Zura Bio, and Sangamo Therapeutics saw notable declines, with SINTX Techs dropping by 30.4%. Notably, Biolase, Nkarta, and Cutera's movements were influenced by their Q4 earnings reports.
March 22, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cutera shares decreased by 25.87% to $1.71 after the Q4 earnings report, with a market value of $34.0 million.
Cutera's stock price drop following the Q4 earnings report suggests the financial results did not meet market expectations.
CONFIDENCE 95
IMPORTANCE 95
RELEVANCE 95
NEGATIVE IMPACT
Nkarta stock decreased by 28.51% to $9.28 after the Q4 earnings report, with a market cap of $455.3 million.
The decline in Nkarta's stock price following the Q4 earnings report indicates a negative market reaction to the financial results.
CONFIDENCE 95
IMPORTANCE 95
RELEVANCE 95
POSITIVE IMPACT
IMAC Holdings shares surged 91.5% to $2.47, with a market value of $2.8 million.
The significant surge in IMAC Holdings' stock price indicates strong investor interest, likely due to positive developments or expectations.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Biolase shares increased by 25.4% to $0.19, influenced by their Q4 earnings report. The market value is at $3.6 million.
Biolase's stock price increase following the Q4 earnings report suggests the market reacted positively to the financial results.
CONFIDENCE 95
IMPORTANCE 95
RELEVANCE 95
POSITIVE IMPACT
Virios Therapeutics shares increased by 37.98% to $0.46, with a market cap of $8.8 million.
The rise in Virios Therapeutics' stock price suggests positive market sentiment, potentially due to favorable news or investor expectations.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90